Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: prostate  massager  adenocarcinoma  appendix  cancer  patients  health  immunotherapy  dendritic  cell  vaccine  multivu  64654  lung  cancer  screening  legacy  genetech  smokers  risk  mortality  killer  smoking  life  multivu  47244  nfl  football  national  prostate  cancer  awareness  month  health  aua  know  your  stats  multivu  51874  masturbating  progensa  pca3  assay  molecular  test  prostate  cancer  repeat  biopsies  genprobe  fda  healthcare  multivu  53530  prostate  health  evander  holyfield  prostate  cancer  african  american  men  health  multivu  7545851  selenium  prostate  cancer  selenium  protects  from  free  radicals  cancer  prostate  cancer  diagnosis  hybridyne  technologies  proxiscan  frost  sullivan  award  compact  detector  multivu  47727  cancer  awareness  health  men  brian  custer  examination  prostate  pcf  multivu  7598151  college  american  pathologists  meeting  2014  cap14  cancer  molecular  genetic  testing  pathology  medicine  multivu  7270051 
Search // prostate
Results 1-12 of 23 for ' prostate ' (0 seconds)
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan. “For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.” To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
Categories // Miscellaneous 
Added: 3473 days ago by MultiVuVideos
Runtime: 1m0s | Views: 970 | Comments: 0
Not yet rated
 

 

 

Steve Scott became one of the greatest mile runners in American history by taking a strategic approach to his craft. Now 58, Scott is seeking a competitive advantage of a different sort since recently being diagnosed with prostate cancer. Scott publicly revealed his current cancer battle today at the Cougar Challenge, a cross country meet at California State University San Marcos, where he is head coach of the track and field and cross country programs. To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7350051-scripps-health-steve-scott-reveals-proton-treatments-for-prostate-cancer
Categories // Miscellaneous  Sport 
Added: 3447 days ago by MultiVuVideos
Runtime: 4m59s | Views: 1018 | Comments: 2
Not yet rated
 

 

 

The Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) are once again teaming up to hit home runs for prostate cancer research and encourage fans to “Keep Dad in the Game” as part of the yearly celebration of Father’s Day and annual Home Run Challenge. This year Joe Torre, MLB’s Chief Baseball Officer, Hall of Famer and prostate cancer survivor, encourages baseball fans everywhere to support PCF’s efforts to end prostate cancer by delivering an important public service announcement, “to step up to the plate, help save lives and get one step closer to finding a cure.” “Joe has been a great partner in our progress toward improved treatment outcomes and an eventual cure,” said PCF Founder and Chairman Mike Milken. “His work as well as those by MLB and all 30 Clubs has helped us raise more than $45 million for research programs that are saving thousands of lives.” To view the multimedia release go to: http://www.multivu.com/players/English/7729251-pcf-and-mlb-prostate-home-run-challenge/
Categories // Miscellaneous 
Added: 2856 days ago by MultiVuVideos
Runtime: 0m30s | Views: 797 | Comments: 0
Not yet rated
 

 

 

The Prostate Cancer Foundation (PCF) announces the launch of the “Step Up for Blue” Campaign for Prostate Cancer Awareness Month. The campaign honors the millions of men and their families touched by prostate cancer worldwide. “Step Up for Blue” focuses on elevating critical issues to inspire, energize, and accelerate actions that lead to greater awareness, new therapies, and fewer deaths from prostate cancer. It will run through the duration of September. To view the multimedia release go to: http://www.multivu.com/players/English/7729253-pcf-step-up-for-blue-prostate-cancer/
Categories // Miscellaneous 
Added: 2765 days ago by MultiVuVideos
Runtime: 1m29s | Views: 615 | Comments: 0
Not yet rated
 

 

 

Nearly 12 million men in the U.S. suffer from symptoms related to benign prostatic hyperplasia (BPH), an enlargement of the prostate that can cause issues such as frequent and weak urinary streams and sleep deprivation from getting up repeatedly during the night to urinate. Since traditional BPH therapies such as daily medications and more invasive or surgical procedures often result in unwanted side effects and complications, more than 54 percent of men who would benefit from treating their BPH choose not to do anything1. With today’s national introduction of the FDA-cleared Rezūm® System, NxThera provides urologists and their patients suffering from symptomatic BPH with a new, safe and effective minimally-invasive, office-based treatment option which improves quality of life and preserves sexual function2 – one of the main reasons many men choose to forego medications or more invasive procedures. “Men suffering from BPH are constantly evaluating the trade-offs between maintaining their current declined quality of life or treating their BPH symptoms and possibly incurring long term side effects,” said Dr. Kia Michel, M.D., a urologist at Comprehensive Urology in Los Angeles who recently performed the procedure as part of a nationally televised segment on prostate health. “Of all the minimally-invasive BPH treatments I’ve performed, Rezūm is the most effective and most versatile treatment available to patients – and the results have been excellent.” To view the multimedia release go to: http://www.multivu.com/players/English/7933151-nxthera-rezum-therapy/
Categories // Miscellaneous 
Added: 2733 days ago by MultiVuVideos
Runtime: 0m57s | Views: 745 | Comments: 0
Not yet rated
 

 

 

Dendreon Corporation (Nasdaq: DNDN) announced significant milestones that support broad availability for on-label use of PROVENGE® (sipuleucel-T), the first autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer (mCRPC). To view Multimedia News Release, go to http://www.multivu.com/mnr/50924-dendreon-provenge-cellular-immunotherapy
Categories // Business 
Added: 4649 days ago by MultiVuVideos
Runtime: 3m36s | Views: 9784 | Comments: 1
Not yet rated
 

 

 

EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
Categories // News and Politics 
Added: 4699 days ago by MultiVuVideo
Runtime: 3m32s | Views: 6731 | Comments: 0
Not yet rated
 

 

 

With September marking National Prostate Cancer Awareness Month and the kick-off of the 2015 NFL season, the Urology Care Foundation and the NFL have renewed their commitment to driving prostate health awareness, as well as teamed up to highlight a Public Service Announcement (PSA) focused on educating men about prostate cancer and encouraging them to take charge of their health through the Know Your Stats® campaign. The Know Your Stats® campaign is a rallying force to connect, educate and inspire men across the country to know their prostate cancer risk and talk to their doctor about whether prostate cancer testing is right for them. “It is important for men to know their risk and talk to their doctors so they can determine if prostate cancer testing is right for them,” said Richard A. Memo, MD, Chair of the Urology Care Foundation. “Having the tools and facts empowers individuals and their doctors to make informed decisions.” Prostate cancer is the second most common cancer in America, affecting one in seven men. Odds increase to one in five if they are African American and one in three if they have a family history; however, the educational tools are making an impact. More men are talking with their doctors and getting tested, and fewer men are dying from the disease. To view the multimedia release go to: http://www.multivu.com/players/English/7365551-prostate-cancer-know-your-stats-psa/
Categories // Miscellaneous 
Added: 3123 days ago by MultiVuVideos
Runtime: 0m37s | Views: 756 | Comments: 0
Not yet rated
 

 

 

The sixth annual Productive Innovation Index released by IDEA Pharma today, which ranks biopharmaceutical companies by their ability to successfully bring innovations to market, sees Johnson & Johnson top the industry for the fourth year running. The Productive Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance data based on a rolling five year period (2010-2015), and operates on the premise: if you gave the same molecule to two different companies in early phase, which would make the best of it? The success of the Janssen Pharmaceutical Companies of Johnson & Johnson and its consolidation of 1st place across the past four years’ rankings is driven largely by innovations in the field of oncology, immunology, neuroscience and cardiovascular/metabolism. Notable performers include Zytiga® (prostate cancer), Imbruvica® (chronic lymphocytic leukemia and mantle cell lymphoma (co-developed and co-marketed with Pharmacyclics, an AbbVie company)), Simponi®/Simponi Aria® (rheumatoid arthritis), Stelara® (psoriasis and psoriatic arthritis), Invega Sustenna® and Invega Trinza® (schizophrenia). To view the multimedia release go to: http://www.multivu.com/players/uk/7770851-johnson-and-johnson-tops-idea-pharma/
Categories // Miscellaneous 
Added: 2954 days ago by MultiVuVideos
Runtime: 3m36s | Views: 729 | Comments: 0
Not yet rated
 

 

 

Seeking to support men and their loved ones facing the challenges that come with a diagnosis of prostate cancer, USA Rugby, the Australian Rugby Union and Astellas Pharma have partnered to launch the #pass4prostate challenge, a social media campaign designed to generate awareness of prostate cancer and support a donation of up to $125,000 from Astellas to four research and advocacy organizations: Prostate Cancer Foundation, Australia Prostate Cancer Research, Prostate Cancer Foundation Australia and Prostate Cancer Canada. From August 5 through the end of September – Prostate Cancer Awareness Month – social media users are encouraged to record a video of themselves catching an inanimate object, mentioning why prostate cancer awareness is important to them, and then passing that object, rugby-style, symbolically to a friend or family member. Astellas will donate $5 to prostate cancer advocacy organizations for every qualifying submission with the #pass4prostate hashtag posted to Facebook, Twitter or Instagram, up to a maximum contribution of $125,000. To view the multimedia release visit: http://www.multivu.com/players/English/7579051-pass4prostate-challenge-rugby-astellas/
Categories // Miscellaneous 
Added: 3157 days ago by MultiVuVideos
Runtime: 0m17s | Views: 830 | Comments: 0
Not yet rated
 

 

 

With September marking the kickoff of the pro-football season and National Prostate Cancer Awareness Month, the Urology Care Foundation and the National Football League (NFL) teamed up to release a new Public Service Announcement (PSA) focused on educating men about prostate cancer and encouraging them to join the Know Your Stats® campaign. To view Multimedia News Release, go to http://www.multivu.com/mnr/63352-nfl-and-urology-care-foundation-national-prostate-cancer-awareness-month
Categories // People and Blog  Sport 
Added: 3830 days ago by MultiVuVideos
Runtime: 0m30s | Views: 2187 | Comments: 2
Not yet rated
 

 

 

New science in molecular and genetic testing for breast, colon, and prostate cancer, as well as leukemia, will be among the special features at the College of American Pathologists’ annual scientific and education meeting, CAP’14—THE Pathologists’ Meeting, Sept. 7-10 at the Hyatt Regency in Chicago. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7270051-college-of-american-pathologists-cap-14-what-s-next-in-cancer-testing/
Categories // Science and Technology 
Added: 3516 days ago by MultiVuVideos
Runtime: 5m19s | Views: 701 | Comments: 0
Not yet rated
 

 

 

Page 1 of 2  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.